Pharmagreen Biotech Inc.

PHBI OTC SEC CIK 1435181
Follow Pharmagreen Biotech Weekly email: filings, results

Financials

Reported figures only · latest: fiscal 2022 USD · US GAAP
Net income −$875.5K +80.7% vs prior year
EPS, diluted -
Operating cash flow −$426.6K −107% vs prior year
Operating income −$1.1M −48% vs prior year
Net income by fiscal year
−$1.1M
−$767.5K
−$2.5M
−$4.5M
−$875.5K
FY18 FY19 FY20 FY21 FY22

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income6 fiscal years
−$6M−$4M−$2M$0FY17FY18FY19FY20FY21FY22
Show the numbers
YearNet income
FY22−$875.5K
FY21−$4.5M
FY20−$2.5M
FY19−$767.5K
FY18−$1.1M
FY17-